-
1
-
-
0027178535
-
Metastatic non-small cell lung cancer
-
Ettinger DS. Metastatic non-small cell lung cancer. Lung Cancer 1993;9:569-70.
-
(1993)
Lung Cancer
, vol.9
, pp. 569-570
-
-
Ettinger, D.S.1
-
2
-
-
1842284787
-
Chemotherapy of non-small cell lung cancer
-
Shields TW. Malvern, PA: Williams & Wilkins
-
Cohen MH. Chemotherapy of non-small cell lung cancer. In: Shields TW. General thoracic surgery. 4th edition. Malvern, PA: Williams & Wilkins, 1994:1229-40.
-
(1994)
General Thoracic Surgery. 4th Edition
, pp. 1229-1240
-
-
Cohen, M.H.1
-
3
-
-
0027502954
-
New chemotherapeutic agents in non-small-cell lung cancer
-
Feigal EG, Christian M, Cheson B, Grever M, Friedman MA. New chemotherapeutic agents in non-small-cell lung cancer. Semin Oncol 1993;20:185-201.
-
(1993)
Semin Oncol
, vol.20
, pp. 185-201
-
-
Feigal, E.G.1
Christian, M.2
Cheson, B.3
Grever, M.4
Friedman, M.A.5
-
4
-
-
0029042825
-
Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
-
Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995;12:199-220.
-
(1995)
Lung Cancer
, vol.12
, pp. 199-220
-
-
Cella, D.F.1
Bonomi, A.E.2
Lloyd, S.R.3
Tulsky, D.S.4
Kaplan, E.5
Bonomi, P.6
-
5
-
-
0026723301
-
Taxol: The first of the taxanes, an important new class of antitumor agents
-
Rowinsky EK, Onetto N, Canetta RM, Arbuck SG. Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 1992;19:646-62.
-
(1992)
Semin Oncol
, vol.19
, pp. 646-662
-
-
Rowinsky, E.K.1
Onetto, N.2
Canetta, R.M.3
Arbuck, S.G.4
-
6
-
-
0027412646
-
Phase II study of taxol in patients with untreated advanced non-small cell lung cancer
-
Murphy WK, Fossella FV, Winn RL, Shin DM, Hynes HE, Gross HM, et al. Phase II study of taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 1993;185:384-8.
-
(1993)
J Natl Cancer Inst
, vol.185
, pp. 384-388
-
-
Murphy, W.K.1
Fossella, F.V.2
Winn, R.L.3
Shin, D.M.4
Hynes, H.E.5
Gross, H.M.6
-
7
-
-
0027537911
-
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group results
-
Chang A, Kim K, Click J, Anderson T, Karp D, Johnson D. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: the Eastern Cooperative Oncology Group results. J Natl Cancer lnst 1993;85:388-94.
-
(1993)
J Natl Cancer Lnst
, vol.85
, pp. 388-394
-
-
Chang, A.1
Kim, K.2
Click, J.3
Anderson, T.4
Karp, D.5
Johnson, D.6
-
8
-
-
0022777093
-
Symptom distress in patients receiving Phase I chemotherapy with taxol
-
Strauman JJ. Symptom distress in patients receiving Phase I chemotherapy with taxol. Oncol Nurs Forum 1986;13:40-3.
-
(1986)
Oncol Nurs Forum
, vol.13
, pp. 40-43
-
-
Strauman, J.J.1
-
9
-
-
0027407786
-
The functional assessment of cancer therapy scale: Development and validation of the general measure
-
Cella DF, Tulsky DS, Gray G, Sarafian G, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Owcol 1993;11:570-9.
-
(1993)
J Clin Owcol
, vol.11
, pp. 570-579
-
-
Cella, D.F.1
Tulsky, D.S.2
Gray, G.3
Sarafian, G.4
Linn, E.5
Bonomi, A.6
-
10
-
-
0027999966
-
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion
-
Eisenhauer EA, ten Bokkel Huiniink WW, Swenerton KD, Giarmi L, Myles J, van der Burg MEL, et al. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol 1994;12:2654-66.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2654-2666
-
-
Eisenhauer, E.A.1
Ten Bokkel Huiniink, W.W.2
Swenerton, K.D.3
Giarmi, L.4
Myles, J.5
Van Der Burg, M.E.L.6
-
11
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Stat Assoc 1958:53:457-81.
-
(1958)
J Amer Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
12
-
-
0029558573
-
Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: A phase II trial
-
Gatzemeier U, Heckmayer M, Neuhauss R, Schluter I, von Pawel J, Wagner H, et al. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial. Semin Oncol 1995;22(6 Suppl 15):24-8.
-
(1995)
Semin Oncol
, vol.22
, Issue.6 SUPPL. 15
, pp. 24-28
-
-
Gatzemeier, U.1
Heckmayer, M.2
Neuhauss, R.3
Schluter, I.4
Von Pawel, J.5
Wagner, H.6
-
13
-
-
0029003733
-
Paclitaxel by 1-hour infusion: An active drug in metastatic non-small-cell lung cancer
-
Hainsworth JD, Thompson DS, Greco FA. Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer. J Clin Oncol 1995;13:1609-14.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1609-1614
-
-
Hainsworth, J.D.1
Thompson, D.S.2
Greco, F.A.3
-
14
-
-
9044222488
-
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell Lung cancer
-
Millward MJ, Bishop JF, Friedlander M, Levi JA, Goldstein D, Olver IN, et al. Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell Lung cancer. J Clin Oncol 1996;14:142-8.
-
(1996)
J Clin Oncol
, vol.14
, pp. 142-148
-
-
Millward, M.J.1
Bishop, J.F.2
Friedlander, M.3
Levi, J.A.4
Goldstein, D.5
Olver, I.N.6
-
15
-
-
0012236681
-
Randomized trial of two doses of taxol in metastatic breast cancer: An interim analysis
-
Nabholtz JM, Gelmon K, Bontenbal M, Spielmann M, Clavel M, Seeber S, et al. Randomized trial of two doses of taxol in metastatic breast cancer: an interim analysis [meeting abstract]. PTOC Am Soc Clin Oncol 1993;12:A42.
-
(1993)
PTOC Am Soc Clin Oncol
, vol.12
-
-
Nabholtz, J.M.1
Gelmon, K.2
Bontenbal, M.3
Spielmann, M.4
Clavel, M.5
Seeber, S.6
-
16
-
-
0028895649
-
Symptom relief with MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in advanced non-small cell lung cancer
-
Ellis PA, Smith IE, Hardy JR, Nicholson MC, Talbot DC, Ashley SE, et al. Symptom relief with MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in advanced non-small cell lung cancer. Br J Cancer 1995;71:366-70.
-
(1995)
Br J Cancer
, vol.71
, pp. 366-370
-
-
Ellis, P.A.1
Smith, I.E.2
Hardy, J.R.3
Nicholson, M.C.4
Talbot, D.C.5
Ashley, S.E.6
-
17
-
-
0024347325
-
Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer
-
Hardy JR, Noble T, Smith IE. Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. Br J Cancer 1989;160:764-6.
-
(1989)
Br J Cancer
, vol.160
, pp. 764-766
-
-
Hardy, J.R.1
Noble, T.2
Smith, I.E.3
-
18
-
-
0029156749
-
Quality of life in phase II trials: A study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor
-
Seidman AD, Portenoy R, Yao T-J, Lepore J, Mont EK, Kortmansky J, et al. Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst 1995;87:1316-22.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 1316-1322
-
-
Seidman, A.D.1
Portenoy, R.2
Yao, T.-J.3
Lepore, J.4
Mont, E.K.5
Kortmansky, J.6
-
19
-
-
0029098178
-
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis
-
Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995;13:1860-70.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1860-1870
-
-
Langer, C.J.1
Leighton, J.C.2
Comis, R.L.3
O'Dwyer, P.J.4
McAleer, C.A.5
Bonjo, C.A.6
|